{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:30:25Z","timestamp":1777480225200,"version":"3.51.4"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"name":"the Joint Funds for the Innovation of Science and Technology of Fujian Province","award":["2023Y9056"],"award-info":[{"award-number":["2023Y9056"]}]},{"name":"Fujian Provincial Clinical Key Specialty Construction Project","award":["2023SZDZK-HYXK"],"award-info":[{"award-number":["2023SZDZK-HYXK"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>\n                    A 79-year-old patient with a history of renal cell carcinoma (RCC) presented with nonspecific upper abdominal pain 6 months ago. Contrast-enhanced CT and MRI did not reveal definitive evidence of malignancy. However,\n                    <jats:sup>68<\/jats:sup>\n                    Ga-LNC1007 (\n                    <jats:sup>68<\/jats:sup>\n                    Ga-FAPI-RGD) PET\/CT demonstrated a significant radiotracer-avid focus in the tail of the pancreas, initially interpreted as a metastatic RCC lesion. Surgical pathology later confirmed the lesion as a neuroendocrine neoplasm (NEN). This case illustrates that neuroendocrine tumors may occasionally be missed by conventional imaging modalities or suspected as other malignancies in certain scenarios, and highlights the potential diagnostic value of\n                    <jats:sup>68<\/jats:sup>\n                    Ga-LNC1007 PET\/CT in detecting neuroendocrine tumors.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006385","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:00:42Z","timestamp":1775077242000},"page":"456-458","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Mimicking Metastatic Renal Cell Carcinoma"],"prefix":"10.1097","volume":"51","author":[{"given":"Jie","family":"Zang","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Fujian Medical University, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fuzhou, China"},{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumeng","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Fujian Medical University, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fuzhou, China"},{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Fujian Medical University, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fuzhou, China"},{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Hu","sequence":"additional","affiliation":[{"name":"Fujian Medical University, Pathology, the First Affiliated Hospital, Fuzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8818-198X","authenticated-orcid":false,"given":"Weibing","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Fujian Medical University, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fuzhou, China"},{"name":"Nuclear Medicine"},{"name":"Fujian Medical University, Fujian Key Laboratory of Precision Medicine for Cancer, the First Affiliated Hospital, Fuzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"R1-20260401","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/RLU.0000000000003811","article-title":"68Ga-DOTA-FAPI-04 PET\/CT in neuroendocrine carcinoma of the liver with elevated AFP level: comparison with 18F-FDG PET\/CT","volume":"47","author":"Ergul","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R2-20260401","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1097\/RLU.0000000000003490","article-title":"68Ga-FAPI PET\/CT versus 68Ga-DOTATATE PET\/CT in the evaluation of a patient with neuroendocrine tumor","volume":"46","author":"Komek","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R3-20260401","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s00259-023-06497-6","article-title":"The inferior performance of [68Ga]Ga-FAPI-04 PET\/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors","volume":"51","author":"Has Simsek","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R4-20260401","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2967\/jnumed.122.264383","article-title":"Prospective phase II trial of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET\/CT imaging of integrin \u03b1v\u03b23 for prognostication in patients with neuroendocrine neoplasms","volume":"64","author":"Carlsen","year":"2023","journal-title":"J Nucl Med"},{"key":"R5-20260401","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.7150\/thno.79144","article-title":"Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [68Ga]Ga-FAPI-RGD","volume":"12","author":"Zang","year":"2022","journal-title":"Theranostics"},{"key":"R6-20260401","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2967\/jnumed.122.265383","article-title":"Clinical evaluation of 68Ga-FAPI-RGD for imaging of fibroblast activation protein and integrin \u03b1v\u03b23 in various cancer types","volume":"64","author":"Zhao","year":"2023","journal-title":"J Nucl Med"},{"key":"R7-20260401","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/RLU.0000000000004820","article-title":"A head-to-head comparison of 68Ga-LNC1007 and 2-18F-FDG\/68Ga-FAPI-02 PET\/CT in patients with various cancers","volume":"48","author":"Zang","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R8-20260401","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00259-023-06436-5","article-title":"68Ga]Ga\u2011LNC1007 PET\/CT in the evaluation of renal cell carcinoma: comparison with 2-[18F]FDG\/[68Ga]Ga-PSMA PET\/CT","volume":"51","author":"Lin","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:00:44Z","timestamp":1775077244000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006385"}},"subtitle":["A Case of Pancreatic Tail Neuroendocrine Neoplasm on 68Ga-LNC1007 PET\/CT"],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006385","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"2025-12-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}